Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices 5117 

novel influenza (H5N1) vaccines, tetanus, 

diphtheria, and acellular pertussis (Tdap) 

vaccine; hepatitis vaccines; new hexavalent 

vaccine work group; yellow fever vaccine; 

smallpox vaccine in laboratory personnel; 

and vaccine supply. Recommendation votes 

are scheduled for general recommendations, 

meningococcal vaccines, influenza, novel 

influenza H5N1 vaccine, yellow fever 

vaccine, smallpox vaccine, and human 

papillomavirus vaccines. Time will be 

available for public comment. 

Agenda items are subject to change as 

priorities dictate. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, National Center for 

Immunization and Respiratory Diseases, 

CDC, 1600 Clifton Road NE., MS–A27, 

Atlanta, Georgia 30333, telephone 404/639– 

8836; Email ACIP@CDC.GOV. 

Meeting is webcast live via the World Wide 

Web; for instructions and more information 

on ACIP please visit the ACIP Web site: 

http://www.cdc.gov/vaccines/acip/

index.html. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–01818 Filed 1–29–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee for Dose 

Reconstruction Reviews (SDRR), 

Advisory Board on Radiation and 

Worker Health (ABRWH or the 

Advisory Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 10:30 a.m.–5:00 p.m., 

Eastern Time, February 27, 2015. 

Place: Audio Conference Call via FTS 

Conferencing. 

Status: Open to the public, but without a 

public comment period. The public is 

welcome to submit written comments in 

advance of the meeting, to the contact person 

below. Written comments received in 

advance of the meeting will be included in 

the official record of the meeting. The public 

is also welcome to listen to the meeting by 

joining the teleconference at the USA tollfree, dial-in number is 1–866–659–0537 and 

the pass code is 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that have 

been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction, which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort. 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to CDC. 

NIOSH implements this responsibility for 

CDC. The charter was issued on August 3, 

2001, renewed at appropriate intervals, and 

will expire on August 3, 2015. 

Purpose: The Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. The Subcommittee for Dose 

Reconstruction Reviews was established to 

aid the Advisory Board in carrying out its 

duty to advise the Secretary, HHS, on dose 

reconstruction. 

Matters for Discussion: The agenda for the 

Subcommittee meeting includes the 

following dose reconstruction program 

quality management and assurance activities: 

Discussion of current findings from NIOSH 

and Advisory Board dose reconstruction 

blind reviews; discussion of dose 

reconstruction cases under review including 

Pacific Proving Grounds, DuPont Deepwater 

Works, and cases from Sets 14–18; the Oak 

Ridge sites (Y–12, K–25, Oak Ridge National 

Laboratory, and Savannah River Site); plans 

for dose reconstruction case reviews; and 

preparation of the Advisory Board’s next 

report to the Secretary, HHS, summarizing 

the results of completed dose reconstruction 

reviews. The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

Theodore Katz, Designated Federal Officer, 

NIOSH, CDC, 1600 Clifton Road NE., 

Mailstop E–20, Atlanta, Georgia 30333, 

Telephone (513) 533–6800, Toll Free 

1(800)CDC–INFO, Email ocas@cdc.gov. The 

Director, Management Analysis and Services 

Office, has been delegated the authority to 

sign Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–01765 Filed 1–29–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns ‘‘Epi-Centers for the 

Prevention of Healthcare-Associated 

Infections, Antimicrobial Resistance and 

Adverse Events-Multicenter Expansion 

of Current Investigation’’, Funding 

Opportunity Announcement (FOA) 

CK11–0010501SUPP15, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12:00 p.m.–4:00 p.m., 

February 23, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters For Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Epi-Centers for the Prevention 

of Healthcare-Associated Infections, 

Antimicrobial Resistance and Adverse 

Events-Multicenter Expansion of Current 

Investigation’’, FOA CK11–0010501SUPP15’’. 

Contact Person for More Information: 

Gregory Anderson, M.S., M.P.H., Scientific 

Review Officer, CDC, 1600 Clifton Road NE., 

Mailstop E60, Atlanta, Georgia 30333, 

Telephone: (404) 718–8833. The Director, 

Management Analysis and Services Office, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES